What is the study about?
A person’s risk of Parkinson’s Disease (PD) may be influenced by genetics. Studying how genes are involved can help us understand what causes the Parkinson’s onset and progression and lead to better treatments.
The Global Parkinson’s Genetics Program (GP2) is an ambitious program to study the genetics of >150,000 volunteers worldwide to understand the genetic risk factors of PD further.
The purpose of the Australian Parkinson’s Genetics Study (APGS) is to establish a national PD cohort study of 20,000 participants, including 10,000 with PD and 10,000 without PD or a family history of PD. This will advance the understanding of the epidemiology, phenotypic and clinical diversity, and genetic risk factors of PD in Australia.
Participation will contribute to research that could help change the face of Parkinson’s disease.